SCINTOMICS Molecular, Applied Theranostics Technologies GmbH

Industry / private company


Location: Fürstenfeldbruck, Germany (DE) DE

close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Potential influence of concomitant chemotherapy on CXCR4 expression in receptor directed endoradiotherapy (2019) Lapa C, Lueckerath K, Kircher S, Haenscheid H, Grigoleit GU, Rosenwald A, Stolzenburg A, et al. Journal article [68Ga]Pentixafor-PET/CT for imaging of chemokine receptor CXCR4 expression in multiple myeloma - Comparison to [18F]FDG and laboratory values (2017) Lapa C, Schreder M, Schirbel A, Samnick S, Kortuem KM, Herrmann K, Kropf S, et al. Journal article CXCR4-directed endoradiotherapy induces high response rates in extramedullary relapsed multiple myeloma (2017) Lapa C, Herrmann K, Schirbel A, Haenscheid H, Luerckerath K, Schottelius M, Kircher M, et al. Journal article